11/04/2015
https://congress.gov...
"It is likely that legislation to address drug pricing will ruffle some feathers, and that is OK."
"I will admit to being frustrated that we are not considering, perhaps, some additional policies."
"Hon. Michael C. Burgess, a Representative in Congress from the State of Texas, opening statement."
"And this is why we are very eager, particularly as we move toward much more expensive biotech drugs in the future to make sure that we are dealing with this problem up front because the problem that w..."